Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-20

Clinical Trial Update: Sex-Specific Cerebrovascular Dysfunction in Metabolic Syndrome-Role of COX [EARLY_Phase 1]

View source ↗

Summary

An early-phase clinical trial at the University of Wisconsin, Madison studying sex-specific cerebrovascular dysfunction in metabolic syndrome and the role of CO…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Metabolic Syndrome | EARLY_Phase 1 | Status: NOT_YET_RECRUITING